BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29616037)

  • 1. MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer.
    Wu J; Ding J; Yang J; Guo X; Zheng Y
    Front Immunol; 2018; 9():546. PubMed ID: 29616037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA and NF-kappa B.
    Yuan Y; Tong L; Wu S
    Adv Exp Med Biol; 2015; 887():157-70. PubMed ID: 26662991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs Regulating NF-κB Signaling.
    Li M; Guan H
    Adv Exp Med Biol; 2016; 927():317-36. PubMed ID: 27376741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
    Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
    Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
    Li Y; Zu L; Wu H; Zhang F; Fan Y; Pan H; Du X; Guo F; Zhou Q
    Thorac Cancer; 2022 Feb; 13(3):430-441. PubMed ID: 34953057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
    Tang C; Zhu G
    Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexity of NF-κB signaling in inflammation and cancer.
    Hoesel B; Schmid JA
    Mol Cancer; 2013 Aug; 12():86. PubMed ID: 23915189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog.
    Feng Y; Zhou S; Li G; Hu C; Zou W; Zhang H; Sun L
    Arch Biochem Biophys; 2016 May; 598():57-65. PubMed ID: 27040383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells.
    Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X
    Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.
    Tong L; Yuan Y; Wu S
    Adv Drug Deliv Rev; 2015 Jan; 81():1-15. PubMed ID: 25220353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer.
    Baldwin AS
    Immunol Rev; 2012 Mar; 246(1):327-45. PubMed ID: 22435564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in NF-kappaB signaling.
    Ma X; Becker Buscaglia LE; Barker JR; Li Y
    J Mol Cell Biol; 2011 Jun; 3(3):159-66. PubMed ID: 21502305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers.
    Li Y; Zhao B; Peng J; Tang H; Wang S; Peng S; Ye F; Wang J; Ouyang K; Li J; Cai M; Chen Y
    Drug Resist Updat; 2024 Mar; 73():101042. PubMed ID: 38219532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
    Zeligs KP; Neuman MK; Annunziata CM
    Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
    Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders.
    Ghafouri-Fard S; Abak A; Fattahi F; Hussen BM; Bahroudi Z; Shoorei H; Taheri M
    Biomed Pharmacother; 2021 Jun; 138():111519. PubMed ID: 33756159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional analysis of MicroRNAs involved in NF-κB signaling.
    Yang Y; Wang JK
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1764-74. PubMed ID: 27212168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.